Related Experiment Video
Updated: Nov 16, 2025
Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
Published on: September 20, 2024
COVID-19, HHV6 and MOG antibody: A perfect storm
Muruj Jumah1, Farah Rahman2, Mark Figgie1
1Neurology Department, University Hospitals of Cleveland, Cleveland, OH, USA.
Background:
Serious neurological complications of SARS-CoV-2 are increasingly being recognized.
Case:
We report a novel case of HHV6 myelitis with parainfectious MOG-IgG in the setting of COVID-19-induced lymphopenia and hypogammaglobulinemia. The patient experienced complete neurological recovery with gancyclovir, high dose corticosteroids, and plasma exchange. To our knowledge, this is the first case of HHV6 reactivation in the central nervous system in the setting of COVID19 infection and the first case of MOG-IgG myelitis in the setting of SARS-CoV-2 and HHV6 coinfection.
Conclusion:
Patients with neurological manifestations in the setting of COVID19-related immunodeficiency should be tested for opportunistic infections including HHV6. Viral infection is a known trigger for MOG-IgG and therefore this antibody should be checked in patients with SARS-CoV-2 associated demyelination.
Related Concept Videos
01:29Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
01:26Pharmacokinetics: Drug–Food and Drug–Viral Interactions
01:25Immunodeficiency Diseases
There are three main causes of immunodeficiency...
01:36Humoral Immune Responses